High level expression of ΔN-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

Oncogene

Volumn 19, Issue 30, 2000, Pages 3439-3444

  Crook, Tim ^a   Nicholls, John M ^b   Brooks, Louise ^c   O'Nions, Jenny ^a   Allday, Martin J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

NPC; p14(ARF); p53; p63; Undifferentiated nusopharyngeal carcinoma

Indexed keywords

MESSENGER RNA; PROTEIN P14; PROTEIN P53; PROTEIN P63; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; DOMINANT INHERITANCE; EXON; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SHORT SURVEY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR BIOPSY; TUMOR CELL; TUMOR SUPPRESSOR GENE; UNDIFFERENTIATED CARCINOMA;

HUMAN HERPESVIRUS 4;

EID: 0034644195     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203656     Document Type: Short Survey

References (42)

1. Alldred D, Clark G, Elledge R, Fuqua S, Brown R, Chamness G, Osborne G and McGuire W. (1993). J. Natl. Cancer Inst., 85, 200-206.
2. Capoulade C, Bressac-de Paillerets B, Lefrere I, Ronsin M, Feuntun J, Tursz T and Wiels J. (1998). Oncogene, 16, 1603-1610.
3. Effert P, McCoy R, Abdel-Hamid M, Flynn K, Zhang Q, Bussion P, Tursz T, Liu E and Raab-Traub N. (1992). J. Viral., 66, 3768-3775.
4. Eischen CM, Weber JD, Roussel MF, Sherr CJ and Cleveland JL. (1999). Genes Dev., 13, 2658-2669.
5. Foulkes WD, Flanders TY, Pollock PM and Hayward NK. (1997). Mol. Med., 3, 5-20.
6. Fries KL, Miller WE and Raab-Traub N. (1996). J. Virol., 70, 8653-8659.
7. Gazzeri S, Gouyer V, Vourch C, Brambilla C and Brambilla E. (1998). Oncogene, 16, 497-504.
8. Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY and Geradts J. (1998). Am. J. Pathol., 152, 865-869.
9. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
10. Klein G. (1979). The Epstein-Barr virus. Epstein MA and Achong BG (eds). Springer-Verlag: Berlin.
11. Kaelin Jr WG. (1999). Oncogene, 18, 7701-7705.
12. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
13. Kubbutat MHG, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
14. Levine A. (1997). Cell, 88, 323-331.
15. Lo KW, Cheung ST, Leung SF, van Hasselt A, Mak KF, Chung YF, Woo JK, Lee JC and Huang DP. (1996). Cancer Res., 56, 2721-2725.
16. Lo KW, Huang DP and Lau KM. (1995). Cancer Res., 55, 2039-2043.
17. Lo KW, Mok CH, Huang DP, Liu YX, Choi PH, Lee JC and Tsao SW. (1992). Anticancer Res., 12, 1957-1963.
18. McGregor JM, Berkhout RJ, Rozycka M, Scheggel J, Bouwes Bavinck JN, Brooks E and Crook T. (1997). Oncogene, 15, 1737-1740.
19. Mills AA, Zheng B, Wang X-J, Vogel H, Roop D and Bradley A. (1999). Nature, 398, 708-713.
20. Murono S, Yoshizaki T, Park CS and Furukawa M. (1999). Histopathology, 34, 432-438.
21. Niedobitek G, Agathanggelou A, Barber P, Smallman LA, Jones EL and Young LS. (1993). J. Pathol., 170, 457-461.
22. Niedobitek G, Agathanggelou A and Nicholls JM. (1996). Semin. Cancer Biol., 7, 165-174.
23. Oliner JD, Kinzler KW, Meltzer PS, George D and Vogelstein B. (1992). Nature, 358, 80-83.
24. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein (1993). Nature, 362, 857-860.
25. Parsa R, Yang A, McKeon F and Green H. (1999). J. Invest. Dermatol., 113,
26. Quelle DE, Zindy F, Ashmun R and Sherr CJ. (1995). Cell, 83, 993-1000.
27. Quelle DE, Cheng M, Ashmun RA and Sherr CJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 3436-3440.
28. Rickinson A and Kieff E. (1996). Fields Virology, 3rd edition. Fields BN, Knipe DM, Howley PM et al. (eds). Lippineott-Raven Publishers: Philadelphia.
29. Ruas M and Peters G. (1998). Biochim. Biophys. Acta., 1378, F115 F177.
30. Sherr CJ. (1998). Cenes Dev., 12, 2984-2991.
31. Schmitt CA, McCurrach ME, de Stachina E, Wallace-Brodeur RR and Lowe SW. (1999). Genes Dev., 13, 2670-2677.
32. Sheu LF, Chen A, Tseng HH, Leu FJ, Lin JK, Ho KC and Meng CL. (1995). Human Pathol., 26, 380-386.
33. Spruck CH, Tsai TC, Huang DP, Yang AS, Rideout WM, Gonzalez-Zulueta M, Choi P, Lo KW, Yu MC and Jones PA. (1992). Cancer Res., 52, 4787-4790.
34. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. (1998). EMBO J., 17, 5001-5014.
35. Sun Y. Hegamyer G, Cheng YJ, Hildesheim A, Chen J-Y, Chen I-H, Cao Y, Kai-Tai Y and Colburn NH. (1992). Proc. Natl. Acad. Sci. USA, 89, 6516-6520.
36. Sun Y, Hilesheim A, Lanier AE, Cao Y, Yao KT, Raab-Traub N and Yang CS. (1995). Oncogene, 10, 785-788.
37. Vousden KH. (1993). FASEB J., 7, 872-879.
38. Yang A, Kaghad M, Wang Y, Gillet E. Flemming MD, Dotsch V, Andrews NC, Caput D and McKeon F. (1998). Mol. Cell., 2, 305-316.
39. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C and McKeon F. (1999). Nature, 398, 714-718.
40. ZhangY and Xiong Y. (1999). Mol. Cell., 3, 579-591.
41. Zhang Y, Xiong Y and Yarborough WG. (1998). Cell, 92, 725-734.
42. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.